FOXD1 and colon adenocarcinoma: Our findings further confirm that FOXD1 expression in COAD tissues exceeds normal levels and shows significant correlation with multiple immune cell infiltrations, indicating its potential as a biomarker for predicting COAD prognosis and immune microenvironment status.